Pfizer Inc.
NEW YORK and MALVERN, Pennsylvania, December 16, 2010 - Pfizer Inc.
NEW YORK, December 6, 2010 - Pfizer Inc.
NEW YORK, December 2, 2010 - Pfizer Inc.
NEW YORK and CARMIEL, Israel, November 29, 2010 - Pfizer Inc.
NEW YORK, October 28, 2010 - Pfizer Inc.(NYSE: PFE) announced today that the Japanese Ministry of
Health, Labour and Welfare approved Lyrica(R) (pregabalin) capsules for the
treatment of peripheral neuropathic pain.
More News
- Findings From Largest MRSA Nosocomial Pneumonia Study Conducted to Date Were Presented During IDSA Annual Meeting
- Updated Study Results to be Presented on ALK inhibitor (PF-02341066) and Pan-HER Inhibitor (PF-00299804) in Non-Small Cell Lung Cancer
- Results Presented at the Annual Meeting of the European Academy of Dermatology and Venereology in Gothenburg, Sweden
- EU Regulation Allows Pfizer to Apply to Extend Lipitor Patent Protection by Six Months in Certain EU Countries
- Caduet Reduces 10-Year Calculated Risk of Coronary Heart Disease, Fatal Cardiovascular Disease
- ASA Concludes Pfizer’s Hard Hitting Counterfeit Medicines Advert ‘Did Not Breach Code’
